Victor L. Villemagne

Victor L. Villemagne

145 Studley Road
Heidelberg, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 412 publications

Effects on cognition of regional astrogliosis assessed by 18F-SMBT-1 PET in non- demented individuals.

Effects on cognition of regional astrogliosis assessed by 18F-SMBT-1 PET in non- demented individuals.

Journal: Research square

Published: August 20, 2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Journal: JAMA

Published: July 13, 2026

CNS-selective plasma p-tau217 accurately captures Alzheimer's disease pathology and progression.

CNS-selective plasma p-tau217 accurately captures Alzheimer's disease pathology and progression.

Journal: medRxiv : the preprint server for health sciences

Published: June 04, 2026

Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's disease.

Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's disease.

Journal: Research square

Published: May 18, 2026

Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's disease.

Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's disease.

Journal: Research square

Published: May 18, 2026

Plasma amyloid-β predicts amyloid-β accumulation in PET A- non-demented participants.

Plasma amyloid-β predicts amyloid-β accumulation in PET A- non-demented participants.

Journal: Journal of Alzheimer's disease : JAD

Published: March 10, 2026

Characterization of [18F]SMBT-1 binding substrates in Alzheimer's disease and related disorders: A postmortem biochemical and immunohistochemical study.

Characterization of [18F]SMBT-1 binding substrates in Alzheimer's disease and related disorders: A postmortem biochemical and immunohistochemical study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 16, 2026

Complex interplay of astrogliosis and pathology in preclinical Alzheimer's disease.

Complex interplay of astrogliosis and pathology in preclinical Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 28, 2026

Biomarkers.

Biomarkers.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 14, 2026

Analysis of second-generation epigenetic clocks reveals further associations between disproportionate biological ageing and hippocampal volume.

Analysis of second-generation epigenetic clocks reveals further associations between disproportionate biological ageing and hippocampal volume.

Journal: GeroScience

Published: January 12, 2026

Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's disease.

Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's disease.

Journal: EBioMedicine

Published: December 04, 2025

Visual read performance of 18F-Florbetapir and 18F-NAV4694 Aβ PET compared against Centiloid reference standard in a paired cohort.

Visual read performance of 18F-Florbetapir and 18F-NAV4694 Aβ PET compared against Centiloid reference standard in a paired cohort.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: December 04, 2025

Showing 1-12 of 412

Last Updated: 09/26/2026